Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The detection of a wide range of genomic modifications plays an important role in the diagnostics refining individual therapeutic methods of cancer patients. Technologies that help to identify therapeutic relevant goals in tumor samples are a key factor on the way to a personalized medicine.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi